Work

Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab Following Standard Chemotherapy for Patients with Intermediate-High/High Risk Diffuse Large B-Cell Lymphoma (DLBCL) - Final Results

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.2739.2739

Authors: Nishitha M Reddy, David S Morgan, John P Greer, Heidi Chen, Steven I. Park, Kristy L. Richards

Institutions: Vanderbilt University Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Weill Cornell Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980193530

FWCI:

Cites:

Cited by:

Related to: 10